Compare ULBI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ULBI | ACHV |
|---|---|---|
| Founded | 1990 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.9M | 239.0M |
| IPO Year | 1992 | N/A |
| Metric | ULBI | ACHV |
|---|---|---|
| Price | $5.80 | $4.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.50 |
| AVG Volume (30 Days) | 36.3K | ★ 622.0K |
| Earning Date | 11-18-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $186,530,000.00 | N/A |
| Revenue This Year | $31.30 | N/A |
| Revenue Next Year | $6.24 | N/A |
| P/E Ratio | $57.78 | ★ N/A |
| Revenue Growth | ★ 12.94 | N/A |
| 52 Week Low | $4.07 | $1.84 |
| 52 Week High | $9.52 | $5.78 |
| Indicator | ULBI | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 49.80 | 44.93 |
| Support Level | $5.72 | $4.23 |
| Resistance Level | $6.25 | $4.86 |
| Average True Range (ATR) | 0.25 | 0.26 |
| MACD | 0.07 | -0.06 |
| Stochastic Oscillator | 47.05 | 8.85 |
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.